Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
| Fund/benchmark | Change | |
|---|---|---|
| Price | International Biotechnology Trust (Ordinary Share) | -3.93% |
| NAV | International Biotechnology Trust (Ordinary Share) | -0.86% |
| Morningstar's Benchmark | Nasdaq Biotechnology Index | -- |
Key statistics
On Friday, International Biotechnology Trust (IBT:LSE) closed at 610.00, 11.31% above the 52 week low of 548.00 set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Shares outstanding | 37.84m |
|---|---|
| Market cap | 231.41m GBP |
| Total assets | 284.58m GBP |
| Total expense ratio | 1.44% |
| High | 612.00 |
| Low | 606.00 |
| Previous close | 612.00 |
| Average volume | 61.68k |
|---|---|
| YTD Change | -4.98% |
| Beta | 0.2030 |
| Diluted NAV (est) | 678.54 |
| Diluted NAV (last pub) | 686.67 |
| Premium/Discount | -10.10% |
| Net Gearing | +10.04% |
| Annual div (ADY) | 28.10 GBX |
|---|---|
| Annual div yield (ADY) | 4.59% |
| Div ex-date | Dec 21 2023 |
| Div pay-date | Jan 26 2024 |
Data delayed at least 20 minutes, as of Apr 19 2024 16:18 BST.
More ▼
Board of Directors
1/5Kate Cornish-Bowden, Chairman
2/5Gillian Elcock, Independent Director
3/5Caroline Gulliver, Chairman of the Audit Committee
4/5Patrick Magee, Senior Independent Director
5/5Professor Patrick Maxwell, Independent Director
